Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

33.27
+0.01000.03%
Volume:948.58K
Turnover:31.59M
Market Cap:6.32B
PE:-9.41
High:33.76
Open:33.33
Low:32.90
Close:33.26
Loading ...

J.P. Morgan Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
07 May

Director Andrew Lo Reports Disposal of Common Shares of BridgeBio Pharma Inc

Reuters
·
07 May

Mizuho Adjusts Price Target on BridgeBio Pharma to $60 From $53, Maintains Outperform Rating

MT Newswires Live
·
05 May

Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Risk

Benzinga
·
03 May

BridgeBio Pharma call volume above normal and directionally bullish

TIPRANKS
·
03 May

Mizuho Securities Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
03 May

BridgeBio Pharma First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
01 May

BridgeBio Pharma Stock (BBIO) Jumps on Strong Drug Launch

TIPRANKS
·
01 May

Why BridgeBio Pharma, Inc. (BBIO) Surged on Wednesday

Insider Monkey
·
01 May

Q1 2025 BridgeBio Pharma Inc Earnings Call

Thomson Reuters StreetEvents
·
01 May

BridgeBio Pharma Is Maintained at Buy by UBS

Dow Jones
·
30 Apr

BridgeBio price target raised to $55 from $52 at Scotiabank

TIPRANKS
·
30 Apr

BridgeBio price target raised to $72 from $65 at UBS

TIPRANKS
·
30 Apr

BridgeBio Pharma Shares up 6.1% After Q1 Sales of Heart Condition Drug Beat Estimates

THOMSON REUTERS
·
30 Apr

UBS Adjusts Price Target on BridgeBio Pharma to $72 From $65, Maintains Buy Rating

MT Newswires Live
·
30 Apr

BridgeBio price target raised to $50 from $46 at BofA

TIPRANKS
·
30 Apr

S&P 500 Futures Fall In Premarket Trading; Super Micro Computer, ICL Group Lag

Dow Jones
·
30 Apr

Scotiabank Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
30 Apr

Wells Fargo Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
30 Apr

BridgeBio Pharma Shares up 9.6% Premarket After Q1 Sales of Heart Condition Drug Beat Estimates

THOMSON REUTERS
·
30 Apr